KSE - Delayed Quote KRW
JW Pharmaceutical Corporation (001060.KS)
21,900.00
-100.00
(-0.45%)
At close: 3:30:30 PM GMT+9
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Young-Sub Shin | CEO, Head of Sales & Marketing and Inside Director | -- | -- | 1963 |
| Sung-Yeol Lee | CEO, Head of Product Development & Management and Director | -- | -- | -- |
| Jae-Kwang Jeon | Head Managing Director and Head of Public Relation | -- | -- | 1962 |
| Mr. Hyun-seok Han | Head of Product Plant | -- | -- | 1962 |
| Kim Yong Kwan | Development Head & Internal Director | -- | -- | -- |
JW Pharmaceutical Corporation
JW Gwacheon Tower, 38
Gwacheon-daero 7-gil Gyeonggi-do
Gwacheon-si, 13840
South Korea
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is based in Gwacheon-si, South Korea.
Corporate Governance
JW Pharmaceutical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
July 30, 2025 at 10:59 AM UTC - August 4, 2025 at 12:00 PM UTC
JW Pharmaceutical Corporation Earnings Date
Recent Events
December 27, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
000020.KS Dongwha Pharm.Co.,Ltd
6,280.00
+0.96%
234080.KS JW Lifescience Corporation
11,900.00
-0.42%
003090.KS Daewoong Co., Ltd.
20,300.00
+1.75%
069620.KS Daewoong Pharmaceutical Co., Ltd
134,900.00
-4.12%
068760.KQ Celltrion Pharm, Inc.
46,700.00
-1.58%
006280.KS GC Biopharma Corp.
118,100.00
-0.76%
000100.KS Yuhan Corporation
105,000.00
-2.05%